跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Colav-250
Approved
STANDARD
Colav-250
Giyaan Pharma Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b78596a7c2e2da4d
Company
Giyaan Pharma Private Limited
Type
Standard
Approval Details
Approval Id
b78596a7c2e2da4d
Drug Approval Philippines Name
Colav-250
Product Name
Colav-250
Registration Number
DRP-13682-01
Brand Name
Colav-250
Generic Name
Co-amoxiclav
Dosage Form
Powder for Oral Suspension
Dosage Strength
250 mg/ 62.5 mg per 5 mL
Manufacturer
Giyaan Pharma Private Limited
Importer
AMB HK Enterprises Inc.
Distributor
Kaufmann Pharma Inc.
Issuance Date
24 December 2023
Expiry Date
28 March 2028
Pharmacologic Category
Antibacterial (Penicillin and beta-lactamase inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b78596a7c2e2da4d
Type
Standard
Back to Philippines FDA Approvals
Colav-250 - Philippines FDA Drug Approval Details